SCHEMBL1542768

SCHEMBL1542768

COc1c(NC(=O)c2ccc(NCC(F)(F)F)nn2)cc(-c2ccc[nH]c2=O)cc1C(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.42
ABL1 P00519 1/20 0.35
JAK2 O60674 2/20 0.34
CD274 Q9NZQ7 2/20 0.34
CDC25A P30304 1/20 0.34
CDC25B P30305 1/20 0.34
VNN1 O95497 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
PCSK9 Q8NBP7 1/20 0.31
PDE10A Q9Y233 1/20 0.31
KDM4E B2RXH2 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PTGDR Q13258 1/20 0.31
FGFR3 P22607 1/20 0.31
KDR P35968 1/20 0.31
STING1 Q86WV6 1/20 0.31
BTK Q06187 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2127500 0.88 CYP3A4 (0.41) CYP3A4ABL1JAK2CD274PDE10A
SCHEMBL1542446 0.84 CYP3A4 (0.48) CYP3A4ABL1CD274ALDH1A1KDM4E
SCHEMBL1542355 0.82 CYP3A4 (0.43) CYP3A4ABL1CD274ALDH1A1HPGD
SCHEMBL1542562 0.80 SCN5A (0.35) ABL1CD274VNN1IRAK4FGFR3
SCHEMBL1542928 0.79 CYP3A4 (0.44) CYP3A4ABL1JAK2CD274CDC25A
SCHEMBL1542657 0.77 CYP3A4 (0.49) CYP3A4ABL1ALDH1A1KDM4EL3MBTL1
SCHEMBL1542559 0.76 HCAR3 (0.43) CYP3A4ABL1ALDH1A1HPGDTSHR
SCHEMBL1542911 0.76 CYP3A4 (0.49) CYP3A4ABL1CD274ALDH1A1KDM4E
SCHEMBL1542477 0.76 CYP3A4 (0.59) CYP3A4ABL1CDC25ACDC25B
SCHEMBL1542748 0.75 CYP3A4 (0.47) CYP3A4ABL1CD274ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307372-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2012-04-25 EP claimed
EP-2307372-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2011-04-13 EP claimed
EP-2307372-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2012-04-25 EP disclosed
EP-2307372-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2011-04-13 EP disclosed